Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tiffany Bergot
Observed name:
T. Bergot
Institutions:
Institute of Cancer Research,
Inserm,
Université de Bretagne Occidentale,
Génétique, Génomique Fonctionnelle et Biotechnologies
Observed institutions:
Institute of Cancer Research,
Inserm,
Université de Bretagne Occidentale,
Génétique, Génomique Fonctionnelle et Biotechnologies
ORCID:
0000-0003-3681-3217
Observed ORCID:
0000-0003-3681-3217
OpenAlex ID:
A5009906105
Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1 -mutated myelodysplasia
2023
·
Syed A. Mian
, Céline Philippe
, et al.
·
Science Translational Medicine
·
33
PDF
Human Cancer-Associated Mutations of SF3B1 Lead to a Splicing Modification of Its Own RNA
2020
·
Tiffany Bergot
, Eric Lippert
, et al.
·
Cancers
·
16
PDF
Identification of altered cell signaling pathways using proteomic profiling in stable and progressive chronic lymphocytic leukemia
2021
·
Cristina Bagacean
, Cristina Adela Iuga
, et al.
·
Journal of Leukocyte Biology
·
7
De novo variants in the splicing factor gene SF3B1 are associated with neurodevelopmental disorders
2026
·
Kevin Uguen
, Tiffany Bergot
, et al.
·
Nature Communications
·
3
PDF
Vitamin B5 and Succinyl-CoA Improve Ineffective Erythropoiesis in SF3B1 Mutated Myelodysplasia
2021
·
Syed Mian
, Celine Philippe
, et al.
·
Blood
·
3
A novel splice variant of STIM1 alters constitutive calcium entry in SF3B1-mutated cancers.
2026
·
Nelig Le Goux
, Tiffany Bergot
, et al.
·
European Journal of Cell Biology
Targeting the Defective Coa Pathway to Improve Erythropoiesis in Sf3b1-mutant Mds-rs Patients
2023
·
C. Philippe
, S. Mian
, et al.
·
Leukemia Research
Show more works
View as search
Works count:
7
Citation count:
61
H-index:
3
I10-index:
2
Year
Topic
Type